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Case Report
A 60-year-old male was sent to the emergency room
for acute-onset right ankle pain with mild fever in the
early morning.
The doctor, on duty at that time, took the patient’s
history. The patient, a business manager in a trading
company, had many social engagements. He was a
social drinker, with occasional excessive drinking. He
had been taking diuretics for hypertension for 2 years.
He had drunk a large amount of alcohol at a party on
the previous night. He was awoken by right ankle pain
at 02:00. Initially, he thought it was an ankle sprain
from playing golf. However, the pain became increas-
ingly severe, and was associated with redness, swelling,
tenderness and local heat. He wanted painkillers and
struggled to get out of bed. He fell to the ground and
woke his wife. Subsequently, he was sent to our emer-
gency room.
The physical examination noted an obese gentle-
man with an acute ill-looking appearance, body tem-
perature of 38°C, pulse rate of 110/min, respiratory rate
of 25/min, blood pressure of 160/86 mmHg, normal
chest and abdomen, with no open wound over the integ-
ument. Acute synovitis was noted over the right ankle
joint, with severe pain at mild motion. To clarify the
etiology of the arthritis, the doctor aspirated 5 mL of
synovial fluid from the right ankle joint. The fluid was
yellowish and mildly turbid with some whitish crystals.
Under the impression of acute crystal-induced arthritis,
colchicine and diclofenac were prescribed. In addition,
local ice packing was suggested.
The blood test results were as follows: white blood
cell count (WBC), 12,500/mm3; hemoglobin, 13.5g/dL;
platelets, 310,000/mm3; erythrocyte sedimentation rate
(ESR), 15mm/hr; creatinine, 1.2mg/dL; uric acid, 9.6mg/
dL; C-reactive protein (CRP), 2.1 mg/dL; fasting blood
sugar, 125 mg/dL. The synovial fluid analysis revealed:
WBC, 15,000/mm3; polymorphonuclear neutrophils
(PMN), 95%; glucose, 90 mg/dL; and many intracellu-
lar and extracellular needle-shaped crystals by light
microscopy with strong negative birefringence under
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polarizing microscopy. Monosodium urate (MSU) crystals
were considered. A Gram stain was performed at the
same time, but no suspicious pathogens were noted.
A definite diagnosis of acute gouty arthritis (GA)
was made according to the positive MSU crystals in the
synovial fluid. Three-day treatments of colchicine and
diclofenac were prescribed to the patient. He was 
followed up in a rheumatologic clinic after this 3-day
treatment.
Introduction
Acute arthritis is a common condition encountered in
daily clinical practice, in both emergency rooms and
rheumatologic clinics. Crystal-induced arthritis is the
most common cause of acute arthritis in the elderly.
However, other arthritis types or other conditions
mimicking arthritis should be ruled out before making
a definitive diagnosis. According to the affected joint
count, acute arthritis can be classified into acute
monoarthritis (such as crystal-induced arthritis, septic
arthritis, and hemarthrosis) and acute polyarthritis (such
as acute exacerbation of rheumatoid arthritis, atypical
gout, and nodal osteoarthritis) (Table 1). Because the
severity of each disease is variable, we should pay
greater attention to how we handle elderly patients. If
a patient presents with extreme pain, fever, suspicious
septic arthritis, severe tophaceous gout, gastrointestinal
tract bleeding, and unstable systemic condition (renal
dysfunction, heart disease, liver disease, and poor blood
sugar control), admission for further evaluation and
management is mandatory. If a patient presents without
these conditions, they can leave the emergency room
after initial management and receive further treatment
in an outpatient clinic.
The steps for evaluating a patient with acute arthritis
are as follows:
1. History taking. This is the first step of the diagnosis.
The history taking should include the onset and
duration of arthritis, characteristics of the pain, ag-
gravating or relieving factors, previous episodes,
diet, alcohol consumption, and exercise. In addi-
tion, it should include any history of trauma, trav-
eling, organism or sexual exposure, past disease and
drug histories, and family histories of arthritis, immu-
nologic diseases or urolithiasis.
2. Physical examination. Alongside a general physical
examination, local findings, such as acute inflam-
matory reactions, joint deformity, tophi or nodules,
and open wounds, should be examined.
3. Laboratory tests. Blood tests, including a complete
blood count, biochemical analyses (uric acid, renal
and liver function, cholesterol and triglyceride, and
blood sugar levels), inflammatory markers (CRP and
ESR) and rheumatoid factor, are helpful. Urinary
tests can detect hematuria, proteinuria, 24-hour
uric acid excretion, and 24-hour creatinine clear-
ance. To rule out cellulitis and septic arthritis from
direct inoculation or hematogenous dissemination,
a blood culture should be performed in febrile
patients, and a pus culture for a suppurative
wound.
4. Synovial fluid analysis. A definite diagnosis of acute
arthritis cannot be made by history taking and
physical examination alone. An arthrocentesis can
be performed on a swollen joint, as long as there
are no contraindications, such as overlying infec-
tion or severe dermatitis, to relieve the swelling,
avoid joint damage, and diagnose the etiology of
the arthritis. If septic synovial fluid is not likely, a
local steroid injection can be given to rapidly relieve
the inflammation. Synovial fluid can be divided into
four groups: non-inflammatory, inflammatory,
septic, and hemorrhagic (Table 2). The appearance,
viscosity, protein, glucose, white and red cell
counts, and PMN percentages under light micros-
copy differ among these four groups. Crystal-induced
arthritis is highly suspected if intracellular needle-
or rhomboid-shaped crystals are noted. A definite
diagnosis can be made according to the refrin-
gence of the crystals under polarizing microscopy.
Gram staining and bacterial cultures with a sensi-
tivity test should be carried out if septic arthritis is
suspected.
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Table 1. Differential diagnosis of acute arthritis
Acute monoarthritis Acute polyarthritis
Crystal-induced arthritis Atypical gout
Gout Nonsuppurative septic arthritis
Pseudogout Rheumatoid arthritis






Hallux valgus with bunion
5. Imaging studies.
• Plain film. The presentation of acute arthritis
on plain film is usually soft tissue swelling
(Figure 1). Other findings are not necessarily
associated with the pathology of this episode.
For example, most elderly people show osteo-
arthritic changes on knee X-rays. However, these
are not usually the cause of acute arthritis.
Acute arthritis usually takes longer or needs
several episodes to develop characteristic joint
damage, such as bone erosion and tophi.
• Soft tissue sonography. Acute arthritis usually
presents as a hypoechoic lesion, with synovial
hyperplasia and hypervascularity. Aspiration of
synovial fluid under echo guidance will facili-
tate a correct diagnosis.
Gout
GA is the most common crystal-induced arthritis. The
pathogenesis is abnormal purine metabolism and/or
decreased urate excretion, such that MSU crystals are
deposited in joints or other tissues to induce an
inflammatory reaction. GA can be divided into pri-
mary and secondary cases. Ninety percent of primary
GA is due to decreased urate excretion. Secondary GA
is mostly from renal diseases, diseases causing high
cell turnover such as myeloproliferative or lympho-
proliferative disorders, psoriasis, chemotherapy for
malignancy, and the side effects of drugs.
Risk factors
Hyperuricemia is the most important biochemical
basis of gout. Higher levels of serum uric acid lead to
higher incidences of GA1. Generally speaking, the serum
uric acid level increases with age. The level rises by
1–2 mg/dL after adolescence in males. In females,
however, it stays at a low level before menopause and a
very low incidence of gout in premenopausal females
is noted. In Taiwan, the prevalences of hyperuricemia
are around 25.8% and 15.0% in males and females,
respectively, and the incidences of GA are 2.9% and
0.45% in males and females, respectively2. Depressed
renal excretion of uric acid owing to some renal diseases,
loop or thiazide diuretics, and low-dose aspirin use
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Table 2. Synovial fluid analysis
Disease category Appearance Viscosity
WBC PMN Protein Glucose 
(×103/mm3) (%) (g/dL) (% plasma)
Non-inflammatory > 4 mL
Osteoarthritis Straw, clear High 1–3 < 30 2–4 80–100
Traumatic arthritis Straw, clear High 1–3 < 30 2–4 80–100
Inflammatory > 4 mL
Rheumatoid arthritis Straw, cloudy Low 10–30 > 90 5–8 80
Reiter’s syndrome Straw, cloudy Low 10–30 > 90 5–8 80
Gout Straw, clear Low 10–30 > 90 5–8 80
Septic > 4 mL
Gonococcal arthritis Straw, slightly cloudy Very low 5–25 > 90 5–8 10–50
Other bacterial arthritis Creamy, thick Very low > 50 > 90 7–8 10–50
Mycobacterium Creamy, thick Very low 10–20 60–80 7–8 10–50
Hemorrhagic > 4 mL, red High As blood As blood As blood 100
WBC = white blood cell count; PMN = polymorphonuclear neutrophils.
Figure 1. X-ray of acute arthritis usually reveals soft tissue
swelling without specific finding.
are common in patients with hypertension and cardiac
diseases, especially in the elderly. Other risk factors for
hyperuricemia include race, genes, obesity, fast body
weight change, drugs (antituberculosis agents such as
ethambutol and pyrazinamide, niacin, cyclosporine,
and didanosine), drinking alcohol, high purine intake,
hypercatabolic state, extreme exercise, trauma, seasonal
or climate change, and chemical exposure3.
Clinical manifestations
The clinical manifestations of GA can be divided into
four stages: asymptomatic hyperuricemia; acute GA;
intercritical gout; and chronic tophaceous gout4. Initially,
it presents as recurrent acute monoarthritis, mostly in
the lower extremity joints. Podagra (Figure 2), com-
prising GA at the first metatarsophalangeal (MTP) joint,
is the first manifestation in 60% of gout patients.
Furthermore, 90% of GA patients have podagra during
the disease course. Other joints frequently involved are
the dorsal foot, ankle, knee, finger, wrist, and elbow
joints in that order. Acute GA usually awakens the
patient in the middle of the night after overeating and
drinking or after extreme exercise. It presents as marked
local redness, swelling, heat and tenderness, and even
a bed sheet covering or a wind cannot be tolerated.
Low-grade fever and weakness are usually associated.
The symptoms peak at around 24–48 hours without
suitable treatment. However, atypical gout usually pres-
ents as chronic polyarthritis at the upper or lower
extremity joints in the elderly, often associated with
tophi. In this subtype, acute attacks with severe
inflammatory signs are very uncommon5.
While taking the patient’s history, metabolic syn-
drome or syndrome X, including hyperuricemia, hyper-
tension, type 2 diabetes mellitus, hypertriglyceridemia,
atherosclerosis and obesity, warn of the existence of
gout. In addition, a family history of gout, urolithiasis
and metabolic syndrome imply the suspicion of gout.
By physical examination, we can note local inflamma-
tory reactions and severe pain even with mild contact
or motion. Tophi are often located around inflamed
joints, earlobes and olecranon bursa in patients with a
long history of GA.
Laboratory tests
Blood tests reveal leukocytosis, increased serum uric acid
and inflammatory markers (CRP and ESR). Biochemical
tests often reveal elevated triglyceride, creatinine and
fasting blood sugar. Proteinuria, hematuria and even
casts in urinalysis stress a work-up of renal dysfunc-
tion or urolithiasis.
Synovial fluid analysis
Arthrocentesis can be done directly or under sono-
graphic guidance. The characteristics of synovial fluid in
acute GA are as follows: low viscosity; semi-transparency
to straw-colored; glucose in synovial fluid at about
80% of blood glucose; white cell count elevation to
10,000–50,000/mm3 with PMN >90%. It should be dif-
ferentiated from septic arthritis. MSU crystals in GA 
are needle-shaped, free (extracellular) or engulfed
(intracellular) by PMN under light microscopy, and
exhibit strong negative birefringence under polarizing
microscopy (Figure 3). If septic arthritis is suspected,
Gram staining and bacterial cultures should be carried
out before antibiotic treatment.
Imaging studies
1. Plain film. Soft tissue swelling is usually the single
finding in acute GA. However, bone erosion, joint
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Figure 3. Monosodium urate crystals: needle-shaped, strongly
negatively birefringent under polarized microscopy.
Figure 2. Podagra: acute gouty arthritis over the first
metatarsophalangeal joint.
space narrowing, tophi in the subchondral space
and bone marrow, osteoporosis, the characteristic
“punch-out lesion” and “overhanging sign” (Figure
4), and even fractures are evident after episodes of
recurrence.
2. Soft tissue sonography. In acute stages, a hypo-
echoic lesion can be seen. The sensitivity for bone
erosion is higher with sonography than with plain
film. In addition, aspiration of an area that is difficult
to approach can be carried out under the guidance
of sonography.
3. Renal sonography. Long-term history of GA, chronic
tophaceous gout and symptoms of urolithiasis sug-
gest the necessity of renal echography to search for
a probable renal stone or other renal diseases.
Classification criteria
Clinically, the definite diagnosis of GA is based on the
characteristic MSU crystals in aspirated synovial fluid
from inflamed joints or in tophi. Other features, such as
acute monoarthritis, hyperuricemia and response to
colchicine treatment, can provide clues toward diag-
nosis. The classification criteria of acute GA suggested
by the American Rheumatism Association are (adapted
from Wallace et al.6): (1) presence of characteristic urate
crystals in the joint fluid; (2) a tophus proven to contain
MSU crystals; or (3) presence of six or more of the fol-
lowing 12 clinical/laboratory/radiologic phenomena:
1. More than one attack
2. Maximal inflammation developed within 1 day
3. Attack of monoarticular arthritis
4. Joint redness
5. First MTP joint painful or swollen
6. Unilateral attack involving the first MTP joint
7. Unilateral attack involving tarsal joint
8. Suspected tophus
9. Hyperuricemia
10. Asymmetric swelling within a joint (X-ray)
11. Subcortical cysts without erosion (X-ray)
12. Negative culture from a joint fluid during attack
Treatment
Acute GA
Colchicine, an inhibitor of WBC chemotaxis, should be
given as soon as possible. The effectiveness rate is up
to 90%. However, it drops to 75% if prescribed after
12–24 hours. The acceptable dose is 1–2 mg/day7. In
addition, a full dose of a nonsteroidal anti-inflammatory
drug (NSAID) can be used if the patient can tolerate it.
Local injection of a corticosteroid into severely inflamed
joints is very effective. Systemic corticosteroid or adre-
nocorticotropic hormone injection can be carried out
for severe oligoarticular or polyarticular attacks, or
attack at sites not amenable to aspiration8. It should
be stressed that this is not the time to commence urate-
lowering therapy. If a patient has taken a hypouricemic
agent, they should maintain the treatment. We have
learned that a fluctuation in the uric acid levels will
induce further attacks of GA.
Intercritical gout and chronic gout
Urate-lowering therapy: After elimination of risk fac-
tors and diet control for gout, patients should initiate
hypouricemic agent treatment if they have serum uric
acid levels above 9 mg/dL, three or more acute attacks
per year, tophaceous gout or renal dysfunction. The tar-
get serum uric acid level is less than 6 mg/dL. The hypo-
uricemic agents can be divided into three categories:
1. Uricosuric agents. Benzbromarone increases renal
urate excretion by inhibiting proximal renal tubular
reabsorption of urate. This category of drug is indi-
cated for a renal urate excretion rate of <600mg/day,
provided that the patient has neither urolithiasis nor
renal dysfunction (creatinine clearance <35mL/min).
In addition, drinking a lot of water with the drug, and
alkalization of urine can help to avoid renal toxicity.
2. Xanthine oxidase inhibitors. Allopurinol can facilitate
the dissolution of tophi and inhibit the formation
of tophi and nephrolithiasis. It is indicated for a
daily urate excretion rate >1,100mg, 24-hour creati-
nine clearance < 35 mL/min, tumor lysis syndrome,
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Figure 4. Tophaceous gout: X-ray shows soft tissue swelling,
tophus and overhanging sign.
urolithiasis or tophaceous gout. Its severe side
effect, toxic epidermal necrolysis, should be moni-
tored. Furthermore, interactions with other drugs
should be kept in mind for elevated or depressed
drug concentrations when other drugs are taken
concurrently. Recently, febuxostat, a non-purine
xanthine oxidase inhibitor, was developed. This drug
seems more potent and safer in renal-impaired
patients than allopurinol. However, it has not yet
been approved for clinical use.
3. Recombinant urate oxidases. This is a new category
of drug. Intravenous rasburicase transforms uric
acid to the more water-soluble allantoin, which is
readily excreted via the kidney. The drug has been
used successfully to prevent dialysis in tumor lysis
syndrome9. However, the antigenicity of rasburic-
ase may limit its application to long-term therapy,
and the optimized regimen for refractory topha-
ceous gout has not been established10. A subcuta-
neous pegylated uricase with a longer half-life and
lower antigenicity was developed. However, these
drugs are not available on the Taiwan market.
For prevention of an acute attack, oral colchicine can
be given at 0.5–1.0 mg/day for patients with frequent
GA attacks and in the first months of urate-lowering
therapy, or at 0.5–1.0 mg statim for patients with
gouty prodromes.
Asymptomatic hyperuricemia
It is not necessary to treat asymptomatic hyperuricemia.
However, it is necessary to monitor the serum uric
acid and creatinine levels to identify the underlying
causes of hyperuricemia and gout, and to treat the
underlying metabolic syndrome (syndrome X, such as
hypertension, type 2 diabetes mellitus, hyperlipidemia,
atherosclerosis and obesity). Urate-lowering therapy is
considered for more than three episodes of acute GA per
year, positive family history of gout or urolithiasis, 24-
hour renal excretion of urate > 1,100 mg, or serum uric
acid > 9 mg/dL for 6 months even under diet control.
Diet and lifestyle remodeling
All GA and hyperuricemic patients should follow the rules
of avoiding high-purine foods (animal visceral organs,
sardines, oysters, clams, crabs, etc.) and large amounts
of alcohol. Drinking more water to maintain at least
2,000mL of urine output, keeping an ideal body weight,
suitable exercise, and avoidance of extreme exercise and
injury, stress and cold environments are all important11.
Pseudogout
Pseudogout, another common crystal-induced arthritis,
is an inflammatory disease caused by accumulation of
calcium pyrophosphate dihydrate. Like GA, the clinical
manifestation is mainly acute monoarthritis, with less
polyarthritis, usually associated with systemic symp-
toms such as fever and malaise. Differential diagnosis
for the two diseases is necessary. The most commonly
affected joints are the knee, wrist and shoulder in
pseudogout, whereas the first MTP joint, dorsal foot
and ankle are frequently involved in GA. In addition,
the inflammation in pseudogout is usually milder than
that in GA. The risk factors for pseudogout include 
elderly age, trauma, genes, and metabolic abnormali-
ties (hyperparathyroidism, hemochromatosis, Wilson’s
disease, etc.).
Leukocytosis and elevated CRP and ESR are com-
mon in pseudogout. Synovial fluid analysis reveals
similar findings to gout, except for differently shaped
crystals. The calcium pyrophosphate dihydrate crys-
tals in pseudogout are short and rhomboid, with weak
positive birefringence under polarizing microscopy,
and are, therefore, different from the needle-shaped
crystals with strong negative birefringence in GA. A plain
film usually shows osteoarthritis, with chondrocalci-
nosis (Figure 5), bone cysts and bone spurs. Avascular
necrosis or fractures may develop after prolonged
inflammation.
The treatment for pseudogout relies on symptom
control. Colchicine, NSAIDs or local steroid injection is
effective in acute episodes. The response is usually
slower than that in gout.
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Figure 5. Chondrocalcinosis, a frequent finding in X-ray, is
most commonly noted at the knee (arrows) and wrist.
Septic Arthritis
Septic arthritis can be divided into gonococcal and non-
gonococcal infections. The latter is far more common
in the elderly, and manifests as acute suppurative
monoarthritis. Staphylococcus aureus is the major path-
ogen, and streptococcal species, Gram-negative aerobes
and anaerobes are unusual. On the other hand, gono-
cocci, viruses, Borrelia burgdorferi (Lyme disease), myco-
bacteria and fungi induce nonsuppurative polyarthritis
with a slower disease course. Septic arthritis usually
attacks diseased joints. For example, rheumatoid arthritis
joints are prone to septic arthritis from hematogenous
spreading of bacteria as a result of synovial hyperplasia.
Other risk factors for septic arthritis are gout, pseudo-
gout, trauma, immunocompromised individuals, intra-
venous drug addiction, and joint replacement.
Acute suppurative arthritis has a rapid disease
course. Patients usually manifest acute arthralgia and
limited range of motion, or acute-on-chronic arthralgia.
Massive joint effusion is usually present. The most com-
monly involved joint is the knee, but the hip, shoulder,
ankle and wrist can also be involved. It is difficult to
differentiate septic arthritis from GA or pseudogout by
clinical symptoms/signs and laboratory tests. The diag-
nosis of septic arthritis relies on the identification of a
pathogen in the synovial fluid. A cloudy-creamy effu-
sion, with a white cell count > 50,000/mm3, PMN > 90%
and elevated protein and depressed sugar contents,
suggests the probability of septic arthritis. A positive
Gram stain can confirm septic arthritis, but a negative
result cannot rule it out. On the other hand, a positive
crystal examination cannot exclude septic arthritis owing
to the possible coexistence of gout and septic arthritis.
A bacterial culture of the synovial fluid should be carried
out to identify the definitive pathogen and facilitate
treatment. For some patients, tuberculous or fungal
cultures are necessary.
Antibiotic treatment should be initiated as soon 
as possible if septic arthritis is suspected. Parenteral
antibiotics are prescribed according to the results of
Gram staining or the empirical antibiotics for the local
regions. After an antibiotic sensitivity test becomes
available, the antibiotic can be changed to a more suit-
able one. Antibiotic treatment should continue for 3–4
weeks, except in cases of gonococcal septic arthritis for
which 2 weeks is adequate. Repeated joint tapping is
necessary for a large amount of joint effusion to attenu-
ate joint damage. Surgical drainage is reserved for joints
in patients who respond poorly to antibiotics, undergo
tapping too frequently, have deeply located areas, or
exhibit periarticular soft tissue infection. The prognosis
of septic arthritis is poor, and permanent joint damage
is frequent with the exception of gonococcal infection.
Hemarthrosis
The most common etiology of hemarthrosis in the
elderly is joint contusion or sprain. Other etiologies
include bleeding tendencies from other diseases and
tumors. The knee, elbow and ankle are frequently
involved. Patients usually present with acute onset of
joint swelling and pain. Severe muscle spasm is noted
at physical examination. Joint tapping is the most valu-
able method to relieve the pain and inflammatory
reactions, and to help the diagnosis, provided no bleed-
ing tendency is present. Hematomatous joint fluid
indicates a recent hemorrhage. However, the joint fluid
turns yellowish after 3–5 days. Synovial fluid analysis
shows a non-inflammatory synovial fluid with a white
cell count < 2,000/mm3 and negative Gram staining.
Ice packs should be prescribed for the injured
joint. After the acute stage, a contrast bath can relieve
joint swelling. NSAIDs improve the pain and inflam-
mation. A protective orthosis is then used to prevent
further injury. After the pain subsides, a repeat physi-
cal examination is necessary to check for meniscus
tears and cruciate ligament rupture. Soft tissue sonog-
raphy or magnetic resonance imaging should be
arranged for a suspicious lesion. Orthopedist consulta-
tion is necessary for arthroscopy.
Osteoarthritis
Osteoarthritis usually presents as chronic arthritis.
However, acute exacerbation is possible especially
after overusing a joint. Tapping of the joint effusion
can help the diagnosis and relieve the symptoms. 
A local steroid injection can be performed to depress
the inflammatory reactions if infection is unlikely.
Other Conditions Mimicking Acute Arthritis
Cellulitis and hallux valgus with bunion formation are
easily mistaken for acute monoarthritis. Comprehensive
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history taking and a physical examination help with
the diagnosis. It should be kept in mind that joint
aspiration and injection should not be performed if
cellulitis is suspected.
Acute Polyarthritis
Atypical gout and nonsuppurative septic arthritis have
slower disease courses, but may also present as acute
arthritis. Other chronic polyarthritis types, such as
rheumatoid arthritis and psoriatic arthritis, flare up
acutely from time to time. Other arthritis types, such as
palindromic rheumatism and nodal osteoarthritis, rarely
cause permanent joint damage. However, Heberden’s
nodes and Bouchard’s nodes may be mistaken for
tophi and these should be carefully differentiated.
Conclusion
Great care should be taken when dealing with acute
arthritis in the elderly. Differential diagnosis and cor-
rect treatment to prevent permanent joint damage are
mandatory.
References
1. Campion EW, Glynn RJ, DeLabry LO. Asymptomatic
hyperuricemia. Risks and consequences in the Normative
Aging Study. Am J Med 1987; 82: 421–6.
2. Lin KC, Lin HY, Chou P. Community-based epidemiolog-
ical study on hyperuricemia and gout in Kin-Hu, Kinmen.
J Rheumatol 2000; 27: 1045–50.
3. Lin KC, Lin HY, Chou P. The interaction between uric
acid level and other risk factors on the development of
gout among asymptomatic hyperuricemic men in a pro-
spective study. J Rheumatol 2000; 27: 1501–5.
4. Wortmann RL, Kelly WN. Gout and hyperuricemia. In:
Kelley’s Textbook of Rheumatology, 7th edition.
Philadelphia: Elsevier Saunders, 2005: 1402–29.
5. Rott KT, Agudelo CA. Gout. JAMA 2003; 289: 2857–60.
6. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ,
Yu TF. Preliminary criteria for the classification of the
acute arthritis of primary gout. Arthritis Rheum 1977;
20: 895–900.
7. Lin YC, Liao HT, Liang TH, Lin HY. The pitfalls in the
diagnosis and treatment of rheumatic diseases. J Intern
Med Taiwan 2004; 15: 147–60.
8. Zhang W, Doherty M, Bardin T, Pascual E, Barskova V,
Conaghan P, et al. EULAR evidence based recommenda-
tions for gout. Part II: Management. Report of a task force
of the EULAR Standing Committee for International
Clinical Studies Including Therapeutics (ESCISIT). Ann
Rheum Dis 2006; 65: 1312–24.
9. Teo WY, Loh TF, Tan AM. Avoiding dialysis in tumour
lysis syndrome: is urate oxidase effective?—a case report
and review of literature. Ann Acad Med Singapore 2007;
36: 679–83.
10. Moolenburgh JD, Reinders MK, Jansen TLTA. Rasburicase
treatment in severe tophaceous gout: a novel therapeutic
option. Clin Rheumatol 2006; 25: 749–52.
11. Lin YC, Lin KC, Lee SS, Lin HY. The difference between
rheumatoid arthritis and gout in epidemiology and health
promotion strategies. J Intern Med Taiwan 2005; 16: 71–8.
International Journal of Gerontology | September 2008 | Vol 2 | No 390
■ ■Y.C. Lin et al
